GrayBella Capital is a pan-European venture capital fund investing in healthcare and complex technology fast growth companies. They invest €2-7M in trenches and welcome other investors on board.
Their goal is to help companies scale internationally while keeping core operations locally in their primary market.
They have a preference for B2B. Their especial focus is on bioinformatics, genomics and other areas where health meets IT. Clinical trials are out of their scope.
Ticket size: €2,000k-€7,000k, maximum allocation with follow-on investments €7,000k per company